6 withdrawn. 6 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Withdrawn 6 |
Follow Eczema: new trials by email Literature Review of Eczema trials Research Report on Eczema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2 Ruxolitinib cream, Vehicle - Chronic Hand Eczema (CHE) | Phase 3 | Withdrawn | Incyte Corporation | 2023-01-31 | 2022-11-10 | |
| Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 1 Ruxolitinib cream, Vehicle - Hand Eczema | Phase 3 | Withdrawn | Incyte Corporation | 2023-01-31 | 2022-11-17 | |
| CBP-201 in Adolescent and Adult Patients With Moderate-to-severe Atopic Dermatitis CBP-201, Placebo - Atopic Dermatitis | Phase 3 | Withdrawn | Connect Biopharm LLC | 2022-12-01 | 2023-03-21 | |
| Management of Eczema by Specific Probiotic Strains Ecologic ® Panda II, placebo - Eczema, Atopic Dermatitis | Phase 3 | Withdrawn | Agentschap NL | 2011-03-01 | 2016-01-12 | |
| Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older MSRD-100, Vehicle - Atopic Dermatitis | Phase 3 | Withdrawn | Merz North America, Inc. | 2016-09-09 | ||
| Efficacy and Safety Study of MSRD-100 in Subjects With Atopic Dermatitis >=3 Months of Age and Older MSRD-100, Vehicle - Atopic Dermatitis | Phase 3 | Withdrawn | Merz North America, Inc. | 2016-09-09 |
Dermatitis (4) · Dermatitis, Atopic (4) · Skin Diseases (4) · Hypersensitivity (3) · Pruritus (3) · Exanthema (2) · Genetic Diseases, Inborn (2) · Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Skin Diseases, Eczematous (2) · Skin Diseases, Genetic (2)
Skin and Connective Tissue Diseases (6) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Skin Diseases, Eczematous (4) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3) · Skin Manifestations (3) · Dermatitis (2) · Genetic Diseases, Inborn (2) · Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Skin Diseases (2) · Skin Diseases, Genetic (2) · Hypersensitivity (1)
Exercise (2)
Incyte Corporation (2) · Merz North America, Inc. (2) · Agentschap NL (1) · Connect Biopharm LLC (1)
Canada (2) · Czechia (2) · Germany (2) · Poland (2) · Spain (2) · United States (2) · Bulgaria (1) · Netherlands (1)
Haq Nawaz, MD (2) · Michael Kuligowski, MD, PhD, MBA (2) · Arine M Vlieger, MD, PhD (1) · Suzhou Connect (1)